OT SELECT SIMPLE METER
Report
- Report Number
- 3008382007-2017-21842
- Event Type
- Injury
- Date Received
- July 11, 2017
- Report Date
- July 7, 2017
- Manufacturer
- LIFESCAN EUROPE, A DIVISION OF CILAG GMBH INTL
- Product Code
- NBW
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- IN
- Reporter Occupation
- PATIENT
Narratives
(B)(4).
ON (B)(6) 2017, THE LAY USER/PATIENT CONTACTED LIFESCAN (LFS) (B)(4) ALLEGING THAT THEIR ONETOUCH SELECT SIMPLE METER HAD READ INACCURATELY HIGH COMPARED TO THEIR FEELINGS AND/OR NORMAL RESULTS. THE COMPLAINT WAS CLASSIFIED BASED ON THE CUSTOMER SERVICE REPRESENTATIVE (CSR) DOCUMENTATION. THE PATIENT REPORTED THAT THE ALLEGED PRODUCT ISSUE STARTED ON (B)(6) 2017. FROM THIS DATE THROUGH UNTIL (B)(6) THE PATIENT OBTAINED POST-PRANDIAL BLOOD GLUCOSE RESULTS IN THE RANGE OF ¿110-159MG/DL¿ AND FASTING BLOOD GLUCOSE RESULTS OF ¿95-115MG/DL¿. THE PATIENT WAS ADVISED THAT THEIR RESULTS SHOULD BE ¿<130MG/DL¿ FOR POST-PRANDIAL AND ¿<95MG/DL¿ FOR FASTING. THE PATIENT DID NOT TAKE ANY MEDICATION IN ORDER TO MANAGE THEIR DIABETES BUT AS A RESULT OF THESE ELEVATED RESULTS THE PATIENT WAS PUT ON AN INSULIN REGIMEN ¿ THEY BEGAN TAKING 5 UNITS OF A ¿MIXTARD 30 FLEXPEN¿ ON (B)(6) 2017. THE FOLLOWING DAY, (B)(6) 2017, THE PATIENT DEVELOPED SYMPTOMS OF ¿BREATHLESS, DROWSINESS, UNEASINESS AND WEAKNESS¿. THE PATIENT DID NOT SEEK ANY TREATMENT INITIALLY, BUT THE FOLLOWING DAY, (B)(6) 2017, THE PATIENT VISITED THEIR DOCTOR WHERE THEY WERE ADVISED TO STOP TAKING THE INSULIN WHICH WAS PRESCRIBED. THE PATIENT¿S BLOOD GLUCOSE WAS MEASURED ON A CALIBRATED LABORATORY DEVICE DURING THIS VISIT AND THE PATIENT OBTAINED BLOOD GLUCOSE RESULTS OF ¿96MG/DL¿ (FASTING) AND ¿108MG/DL¿ (POST-PRANDIAL). NO FURTHER TREATMENT WAS REQUIRED. AT THE TIME OF TROUBLESHOOTING THE CSR NOTED THE UNIT OF MEASURE WAS SET CORRECTLY ON THE SUBJECT METER. THE PATIENT DID NOT HAVE CONTROL SOLUTION AVAILABLE TO WALK THROUGH A CONTROL SOLUTION TEST. THE PATIENT¿S PRODUCTS WERE REPLACED AND REQUESTED FOR EVALUATION. THIS COMPLAINT IS BEING REPORTED BECAUSE THE PATIENT REPORTEDLY DEVELOPED SIGNS/SYMPTOMS THAT MEET LFS¿ CRITERIA FOR A SERIOUS INJURY ADVERSE EVENT AFTER TAKING AN INCREASED DOSE OF INSULIN BASED ON ALLEGED INACCURATE HIGH RESULTS OBTAINED WITH THE SUBJECT METER.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 481935 | OT SELECT SIMPLE METER | GLUCOSE MONITORING SYS/KIT | NBW | LIFESCAN EUROPE, A DIVISION OF CILAG GMBH INTL |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Life Threatening |